REG - Johnson Matthey PLC - Completion of the acquisition of Cormetech

RNS Number : 6445N Johnson Matthey PLC 23 July 2026  

23rd July 2026

Johnson Matthey Plc

• Johnson Matthey completes the acquisition of Cormetech

• Johnson Matthey Plc ("JM") is pleased to confirm that it has today completed the acquisition of CORMETECH Inc. ("Cormetech"), which was announced on 28th May 2026.

• Together with the sale of Catalyst Technologies which completed on 17th July 2026, this represents a significant reshaping of JM's portfolio. As JM transforms into a lean, focused and cash-generative business, built around its leading capabilities in platinum group metal chemistry and emissions control, the group is well-positioned to drive sustainable value creation.

• The combination of JM's Clean Air Solutions business and Cormetech will create a global leader in stationary emissions control, with a significant presence in the rapidly growing data centre market. The businesses bring together highly complementary technologies, leading intellectual property and diverse customer relationships. By strengthening the group's position in an attractive growth market, Cormetech enhances JM's ability to deliver sustainable cash generation and shareholder returns over the long term.

• Liam Condon, Chief Executive Officer, commented:

• Today marks a new chapter for JM. With the completion of the Cormetech acquisition and the sale of Catalyst Technologies, we are now a more focused business, well-positioned to drive sustainable value creation over the long term. I am delighted to welcome our new colleagues from Cormetech to JM and look forward to building on our shared strengths to deliver for our customers and shareholders.

• ENDS

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774

Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  ACQUOOORNNUBUAR